Apolipoprotein E-induced cell signaling in the vessel wall

Reviews in Endocrine and Metabolic Disorders

Volumn 5, Issue 4, 2004, Pages 335-341

  Hui, David Y ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

atherosclerosis; cholesterol transport; endothelial cells; macrophages; neointimal hyperplasia; smooth muscle cells

Indexed keywords

APOLIPOPROTEIN E; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; NITRIC OXIDE SYNTHASE; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROSIS; BLOOD VESSEL WALL; CELL ACTIVATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; CHOLESTEROL TRANSPORT; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE EXPRESSION; MACROPHAGE; MULTIGENE FAMILY; NONHUMAN; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALS; APOLIPOPROTEINS E; BLOOD VESSELS; ENDOTHELIAL CELLS; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; MACROPHAGES; MUSCLE, SMOOTH; RECEPTORS, LDL; SIGNAL TRANSDUCTION;

EID: 6344295056     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:REMD.0000045105.26290.2d     Document Type: Review

References (53)

1. Tsukamoto K, Maugeais C, Glick JM, Rader DJ. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice. J Lipid Res 2000;41:253-259.
2. Mahley RW, Ji ZS. Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 1999;40:1-16.
3. Havel RJ, Hamilton RL. Hepatic catabolism of remnant lipoproteins: Where the action is. Arterioscler Thromb Vasc Biol 2004;24:213-215.
4. Raffai RL, Hasty AH, Wang Y, Mettler SE, Sanan DA, Linton MF, Fazio S, Weisgraber KH. Hepatocyte-derived apoE is more effective than non-hepatocyte-derived apoE in remnant lipoprotein clearance. J Biol Chem 2003;278:11670-11675.
5. Lin CY, Duan H, Mazzone, T. Apolipoprotein E-dependent cholesterol efflux from macrophages: Kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E. J Lipid Res 1999;40:1618-1626.
6. Huang ZH, Mazzone T. ApoE-dependent sterol efflux from macrophages is modulated by scavenger receptor class B type I expression. J Lipid Res 2002;43:375-382.
7. Von Eckardstein A, Langer C, Engel T, Schaukal I, Cignarella A, Reinhardt J, Lorkowski S, Li Z, Zhou X, Cullen P, Assmann, G. ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages. FASEB J 2001;15:1555-1561.
8. Huang ZH, Lin CY, Oram JF, Mazzone T. Sterol efflux mediated by endogenous macrophage apoE expression is independent of ABCA1. Arterioscler Thromb Vasc Biol 2001;21:2019-2025.
9. Shimano H, Yamada N, Katsuki M, Yamamoto K, Gotoda T, Harada K, Shimada M, Yazaki Y. Overexpression of apolipoprotein E in transgenic mice: A marked reduction in plasma lipoproteins except high density lipoprotein, and resistance against diet-induced hypercholesterolemia. Proc Natl Acad Sci USA 1992;89:1750-1754.
10. Shimano H, Yamada N, Katsuki M, Yamamoto K, Gotoda T, Harada K, Shimada M, Yazaki, Y. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B. J Clin Invest 1992;90:2084-2091.
11. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992;258:468-471.
12. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343-353.
13. Kashyap VS, Santamarina-Fojo S, Brown DR, Parrott CL, Applebaum-Bowden D, Meyn, S, Talley G, Paigen B, Maeda N, Brewer HB. Apolipoprotein E deficiency in mice: Gene replacement and prevention of atherosclerosis using adenovirus vectors. J Clin Invest 1995;96:1612-1620.
14. Zhang SH, Reddick RL, Burkey B, Maeda N. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 1994;94:937-945.
15. Shimano H, Ohsuga J, Shimada M, Namba Y, Gotoda T, Harada K, Katsuki M, Yazaki Y, Yamada N. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. J Clin Invest 1995;95:469-476.
16. Hasty AH, Linton MF, Brandt SJ, Babaev VR, Gleaves LA, Fazio, S. Retroviral gene therapy in apoE-deficient mice. ApoE expression in the artery wall reduces early foam cell lesion formation. Circulation 1999;99:2571-2576.
17. Thorngate FE, Rudel LL, Walzem RL, Williams DL. Low levels of extrahepatic nonmacrophage apoE inhibit atherosclerosis without correct hypercholesterolemia in apoE-deficient mice. Arterioscler Thromb Vasc Biol 2000;20:1939-1945.
18. Misra UK, Adlakha CL, Gawdi G, McMillian MK, Pizzo SV, Laskowitz DT. Apolipoprotein E and mimetic peptide initiate a calcium dependent signaling response in macrophages. J Leuk Biol 2001;70:677-683.
19. Hussain MM, Kancha RK, Tulenko TN. Nickel is a specific inhibitor for the binding of activated alpha2-macroglobulin to the low density lipoprotein receptor related protein/alpha2-macroglobulin receptor. Biochemistry 1995;34:16074-16081.
20. Goretzki L, Mueller BM. Low density lipoprotein receptor related protein (LRP) interacts with a GTP-binding protein. Biochem J 1998;336:381-386.
21. Schreiber BM, Jones HV, Franzblau C. Apolipoprotein E expression in aortic smooth muscle cells: The effect of B-VLDL. J Lipid Res 1994;35:1177-1186.
22. Zhu B, Kuhel DG, Witte DP, Hui DY. Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice. Am J Pathol 2000;157:1839-1848.
23. Zhu B, Reardon CA, Getz GS, Hui DY. Both apolipoprotein E and immune deficiency exacerbate neointimal hyperplasia after vascular injury in mice. Arterioscler Thromb Vasc Biol 2002;22:450-455.
24. Moore ZWQ, Zhu B, Kuhel DG, Hui DY. Vascular apolipoprotein E expression and recruitment from circulation to modulate smooth muscle cell response to endothelial denudation. Am J Pathol 2004;164:2109-2116.
25. Ishigami M, Swertfeger DK, Granholm N, Hui DY. Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase. J Biol Chem 1998;273:20156-20161.
26. Ishigami M, Swertfeger DK, Hui MS, Granholm NA, Hui DY. Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 2000;20:1020-1026.
27. Beffert U, Stolt PC, Herz J. Functions of lipoprotein receptors in neurons. J Lipid Res 2004;45:403-409.
28. Herz J, Hui DY. Lipoprotein receptors in the vessel wall. Curr Opin Lipidol 2004;15:175-181.
29. Swertfeger DK, Hui DY. Apolipoprotein E receptor binding versus heparan sulfate proteoglycan binding in Its regulation of smooth muscle cell migration and proliferation. J Biol Chem 2001;276:25043-25048.
30. Vogel T, Guo NH, Guy R, Drezlich N, Krutzsch HC, Blake DA, Panet A, Roberts DD. Apolipoprotein E: A potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem 1994;54:299-308.
31. Swertfeger DK, Bu G, Hui DY. Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration. J Biol Chem 2002;277:4141-4146.
32. Li Y, Lu W, Bu G. Essential role of the low density lipoprotein receptor-related protein in vascular smooth muscle cell migration. FEBS Letters 2003;555:346-350.
33. Loukinova E, Ranganathan S, Kuznetsov S, Gorlatova N, Migliorini MM, Loukinov D, Ulery PG, Mikhailenko I, Lawrence DA, Strickland DK. Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function between LRP and the PDGF. J Biol Chem 2002;277:15499-15506.
34. Boucher P, Liu P, Gotthardt M, Hiesberger T, Anderson RGW, Herz J. Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low density lipoprotein receptor-related protein in caveolae. J Biol Chem 2002;277:15507-15513.
35. Zhu Y, Hui DY. Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A. J Biol Chem 2003;278:36257-36263.
36. Li Y, van Kerkhof P, Marzolo MP, Strous GJ, Bu G. Identification of a major cyclic AMP-dependent protein kinase A phosphorylation site within the cytoplasmic tail of the low-density lipoprotein receptor-related protein: Implication for receptor-mediated endocytosis. Mol Cell Biol 2001;21:1185-1195.
37. Okada SS, Grobmyer SR, Barnathan ES. Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion. Arterioscler Thromb Vasc Biol 1996;16:1269-1276.
38. Wijnberg MJ, Quax PHA, Nieuwenbroek NME, Verheijen JH. The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by alpha2-macroglobulin receptor associated protein. Thromb Haemost 1997;78:880-886.
39. Kanaki T, Bujo H, Hirayama S, Ishii I, Morisaki N, Schneider WJ, Saito Y. Expression of LR11, a mosaic LDL receptor family member, is markedly increased in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1999;19:2687-2695.
40. Zhu Y, Bujo H, Yamazaki H, Hirayama S, Kanaki T, Takahashi K, Shibasaki M, Schneider WJ, Saito Y. Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro. Circulation 2002;105:1830-1836.
41. Paka L, Goldberg IJ, Obunike JC, Choi SY, Saxena U, Goldberg ID, Pillarisetti S. Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth. J Biol Chem 1999;274:36403-36408.
42. Kothapalli D, Fuki I, Ali K, Stewart SA, Zhao L, Yahil R, Kwiatkowski D, Hawthorne EA, FitzGerald GA, Phillips MC, Lund-Katz S, Pure E, Rader DJ, Assoian RK. Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation. J Clin Invest 2004;113:609-618.
43. Bonthu S, Heistad DD, Chappell DA, Lamping KG, Faraci FM. Atherosclerosis, vascular remodeling, and impairment of endothelium dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol 1997;17:2333-2340.
44. Yang R, Powell-Braxton L, Ogaoawara AK, Dybdal N, Bunting S, Ohneda O, Jin H. Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 1999;19:2762-2768.
45. Stannard AK, Riddell DR, Bradley NJ, Hassall DG, Graham A, Owen JS. Apolipoprotein E and regulation of cytokine-induced cell adhesion molecule expression in endothelial cells. Atherosclerosis 1998;139:57-64.
46. Stannard AK, Riddell DR, Sacre SM, Tagalakis AD, Langer C, von Eckardstein A, Cullen P, Athanasopoulos T, Dickson G, Owen JS. Cell-derived apolipoprotein E (apoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J Biol Chem 2001;276:46011- 46016.
47. Sacre SM, Stannard AK, Owen JS. Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells. FEBS Letters 2003;540:181-187.
48. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998;18:842-851.
49. DeMattos RB, Curtiss LK, Williams DL. A minimally lipidated form of cell derived apolipoprotein E exhibits isoform specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins. J Biol Chem 1998;273:4206-4212.
50. Riddell DR, Sun XM, Stannard AK, Soutar AK, Owen JS. Localization of apolipoprotein E receptor 2 to caveolae in the plasma membrane. J Lipid Res 2001;42:998-1002.
51. Riddell DR, Vinogradov DV, Stannard AK, Chadwick N, Owen JS. Identification and characterization of LRP8 (apoER2) in human blood platelets. J Lipid Res 1999;40:1925-1930.
52. Riddell DR, Graham A, Owen JS. Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease. J Biol Chem 1997;272:89-95.
53. Li X, Kypreos K, Zanni EE, Zannis V. Domains of apoE required for binding to apoE receptor 2 and to phospholipids: Implications for the functions of apoE in the brain. Biochemistry 2003;42:10406-10417.